Release Date: August 9, 115 Statement Date: August 8, 115 Statement Time: 7:00:03 Company Code: 6949 Company Name: Per Biotech - Innovation Subject: Announcement of change in par value of company shares from "NT$10" to "NT$0.5". Announcement Period: August 6, 115 to November 5, 115. Applicable Clause: Item 51 Factual Date: July 13, 115 Details: 1. Factual Date: July 13, 115 2. Company Name: Per Biotech Pharmaceutical Co., Ltd. 3. Relationship with Company (please enter本公司or subsidiary):本公司 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: (1) Approval Date / Factual Date of Par Value Change: July 13, 115 (2) Approval Document Number for Par Value Change: Ministry of Economic Affairs Commercial Division No. 11530095510 (3) Board Resolution Date Approving Share Exchange Plan: August 6, 115 (4) Par Value Before Change: NT$10.00 (5) Par Value After Change: NT$0.50 (6) Listing Date for New Shares and Delisting Date for Old Shares: September 7, 115 (7) Material Information Announcement Date for Share Reissuance: Material Information Announcement on August 6, 115 6. Countermeasures: None 7. Other Matters to be Stated: I. The company has completed the procedure to change the par value of its shares from NT$10 to NT$0.5, which has been approved by the Taiwan Stock Exchange. II. In conjunction with the par value adjustment, the reference price on the first trading day of the new shares (September 7, 115) will be adjusted to one-twentieth of the closing price of the old shares on their last trading day (August 26, 115). Investors are advised to take note. III. Following the par value change, earnings per share, net asset value per share, and share price will be adjusted accordingly. Please exercise caution when reviewing financial information.

FACT BOX

  • Source: PR Times
  • Category: News